首页> 外文期刊>JAMA: the Journal of the American Medical Association >Arterial hypertension and renal allograft survival.
【24h】

Arterial hypertension and renal allograft survival.

机译:动脉高压和同种异体肾存活。

获取原文
获取原文并翻译 | 示例
           

摘要

CONTEXT: Several observational studies have investigated the significance of hypertension in renal allograft failure; however, these studies have been complicated by the lack of adjustment for baseline renal function, leaving the role of elevated blood pressure in allograft failure unclear. OBJECTIVE: To examine the relationship between blood pressure adjusted for renal function and survival after cadaveric allograft transplantation. DESIGN: Nonconcurrent historical cohort study conducted from 1985 through 1997. SETTING: University teaching hospital. PARTICIPANTS: A total of 277 patients aged 18 years or older who underwent cadaveric renal transplantation without another simultaneous organ transplantation and whose allograft was functioning for a minimum of 1 year. Follow-up continued through 1997 (mean follow-up, 5.7 years). MAIN OUTCOME MEASURE: Time to allograft failure (defined as death, return to dialysis, or retransplantation) by systolic, diastolic, and mean arterial blood pressure measurements at 1 year after transplantation. RESULTS: Multivariate Cox proportional hazards modeling demonstrated that nonwhite ethnicity, history of acute rejection, and nondiabetic kidney disease were significant predictors of failure (P = .01 for all). In addition, the calculated creatinine clearance at 1 year had an adjusted rate ratio (RR) for allograft failure per 10 mL/min (0.17 mL/s) of 0.74 (95% confidence interval [CI], 0.62-0.88). The RR per 10-mm Hg increase in blood pressure measured at 1 year after transplantation, after adjustment for creatinine clearance, was 1.15 (95% CI, 1.02-1.30) for systolic pressure, 1.27 (95% CI, 1.01-1.60) for diastolic pressure, and 1.30 (95% CI, 1.05-1.61) for mean arterial pressure. Supplemental analyses that did not include death as a failure event or reduce the minimum allograft survival time for study subjects to 6 months yielded results consistent with the primary analysis. There was no evidence of modification of the blood pressure-allograft failure relationship by ethnicity or diabetes mellitus. CONCLUSIONS: Systolic, diastolic, and mean arterial blood pressures at 1 year posttransplantation strongly predict allograft survival adjusted for baseline renal function. More aggressive control of blood pressure may prolong cadaveric allograft survival.
机译:背景:一些观察性研究已经调查了高血压在同种异体肾衰竭中的意义。然而,由于基线肾脏功能缺乏调整,使这些研究变得复杂,因此血压升高在同种异体移植失败中的作用尚不清楚。目的:探讨尸体同种异体移植后经肾脏功能调整的血压与存活率之间的关系。设计:从1985年到1997年进行的非同期历史队列研究。地点:大学教学医院。参与者:共有277名18岁或18岁以上的患者接受了尸体肾移植,而没有同时进行其他器官移植,并且同种异体移植的功能至少持续了1年。随访一直持续到1997年(平均随访时间为5.7年)。主要观察指标:移植后1年通过收缩压,舒张压和平均动脉压测量得出同种异体移植失败的时间(定义为死亡,恢复透析或重新移植)。结果:多变量Cox比例风险模型表明非白人种族,急性排斥反应史和非糖尿病性肾脏疾病是失败的重要预测因子(所有P均= 0.01)。此外,在1年时计算的肌酐清除率对同种异体移植失败的调整比率(RR)/ 10 mL / min(0.17 mL / s)为0.74(95%置信区间[CI],0.62-0.88)。调整肌酐清除率后,移植后1年血压每升高10 mm Hg,RR的收缩压为1.15(95%CI,1.02-1.30),而血压为1.27(95%CI,1.01-1.60)。舒张压,平均动脉压为1.30(95%CI,1.05-1.61)。不包括作为失败事件的死亡或将研究对象的同种异体移植的最短生存时间减少到6个月的补充分析得出的结果与主要分析一致。没有证据表明种族或糖尿病会改变血压与同种异体移植失败的关系。结论:移植后1年的收缩压,舒张压和平均动脉压强烈预测根据基线肾功能调整的同种异体移植存活率。更积极地控制血压可能会延长尸体同种异体移植的存活时间。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号